Structure–activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350

References

Page 1

	Year	Citations
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy, New England Journal of Medicine	2002	6.4K
The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products Oyo Mitsunobu Synthesis EngineeringDiethyl AzodicarboxylateBiochemistryNatural SciencesActive Methylene Compounds	1981	4.1K
A Recyclable Ru-Based Metathesis Catalyst Jason S. Kingsbury, Joseph P. A. Harrity, Peter J. Bonitatibus, Journal of the American Chemical Society Inorganic CompoundInorganic ChemistryChemical EngineeringActive Metathesis CatalystEngineering	1999	933
Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture Volker Lohmann, Sandra Hoffmann, Ulrike Herian, Journal of Virology Viral ReplicationGeneticsMolecular BiologyCell CultureCellular Determinants	2003	389
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients Holger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, Gastroenterology HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2004	331
Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan, Journal of Medicinal Chemistry	2006	278
Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061 Montse Llinàs‐Brunet, Murray D. Bailey, Gordon T. Bolger, Journal of Medicinal Chemistry Competitive Hexapeptide InhibitorsPharmacotherapyAntiviral DrugPharmaceutical ChemistryDrug Resistance	2004	186
Chromenes through Metal-Catalyzed Reactions of Styrenyl Ethers. Mechanism and Utility in Synthesis Joseph P. A. Harrity, Daniel S. La, Dustin R. Cefalo, Journal of the American Chemical Society Disubstituted Styrene EthersChemical EngineeringEngineeringAlkene MetathesisEfficient Metal-catalyzed Process	1998	156
Curtius Rearrangement of Aromatic Carboxylic Acids to Access Protected Anilines and Aromatic Ureas H. Lebel, Olivier Leogane Organic Letters	2006	124
A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors Montse Llinàs‐Brunet, Murray D. Bailey, Élise Ghiro, Journal of Medicinal Chemistry Peptide SubstratesAntiviral DrugChemical BiologyCompetitive Peptide InhibitorsMedicinal Chemistry	2004	122

Page 1